LSE - Delayed Quote GBp

Avacta Group Plc (AVCT.L)

Compare
51.00
0.00
(0.00%)
At close: January 10 at 4:29:46 PM GMT
All All Favorites Text Statistics Technicals Fibonacci Markings Lines
Loading Chart for AVCT.L

Recent News: AVCT.L

View More
While institutions own 41% of Avacta Group Plc (LON:AVCT), individual investors are its largest shareholders with 57% ownership

While institutions own 41% of Avacta Group Plc (LON:AVCT), individual investors are its largest shareholders with 57% ownership
Simply Wall St. 12 days ago
Investors in Avacta Group (LON:AVCT) have seen splendid returns of 163% over the past five years

Investors in Avacta Group (LON:AVCT) have seen splendid returns of 163% over the past five years
Simply Wall St. last month
Avacta Reports Pipeline Advances with Two Novel Programs at the EORTC-NCI-AACR Molecular Targets Symposium in Barcelona

Avacta Reports Pipeline Advances with Two Novel Programs at the EORTC-NCI-AACR Molecular Targets Symposium in Barcelona
GlobeNewswire 2 months ago
Avacta and Tempus Enter Strategic Collaboration to Advance AI-Driven Drug Development in Oncology

Avacta and Tempus Enter Strategic Collaboration to Advance AI-Driven Drug Development in Oncology
GlobeNewswire 2 months ago
Avacta Expands its Pipeline with Two Novel Assets Developed Using its pre|CISION® Platform

Avacta Expands its Pipeline with Two Novel Assets Developed Using its pre|CISION® Platform
GlobeNewswire 2 months ago
Avacta Group strengthens executive team with appointment of Michelle Morrow, PhD as Chief Scientific Officer

Avacta Group strengthens executive team with appointment of Michelle Morrow, PhD as Chief Scientific Officer
GlobeNewswire 2 months ago
Avacta to Unveil Pipeline Expansion and Novel, Next-Generational Targeted Cancer Therapy Programs at 2024 EORTC-NCI-AACR Symposium

Avacta to Unveil Pipeline Expansion and Novel, Next-Generational Targeted Cancer Therapy Programs at 2024 EORTC-NCI-AACR Symposium
GlobeNewswire 3 months ago
Avacta Group First Half 2024 Earnings: UK£0.038 loss per share (vs UK£0.043 loss in 1H 2023)

Avacta Group First Half 2024 Earnings: UK£0.038 loss per share (vs UK£0.043 loss in 1H 2023)
Simply Wall St. 3 months ago
Avacta Reports Updated Phase 1 Clinical Data of AVA6000 at the European Society for Medical Oncology (ESMO) Congress Demonstrating Multiple Ongoing, Durable Responses in Solid Tumors

Avacta Reports Updated Phase 1 Clinical Data of AVA6000 at the European Society for Medical Oncology (ESMO) Congress Demonstrating Multiple Ongoing, Durable Responses in Solid Tumors
GlobeNewswire 3 months ago
Avacta to present updated clinical data on AVA6000 at the European Society for Medical Oncology (ESMO) Congress

Avacta to present updated clinical data on AVA6000 at the European Society for Medical Oncology (ESMO) Congress
GlobeNewswire 4 months ago
Avacta Group Plc's (LON:AVCT) largest shareholders are retail investors with 58% ownership, institutions own 41%

Avacta Group Plc's (LON:AVCT) largest shareholders are retail investors with 58% ownership, institutions own 41%
Simply Wall St. 5 months ago
View More

Related Tickers

SNG.L Synairgen plc
2.0875
-6.49%
 
BSFA.L BSF Enterprise Plc
2.5000
-9.09%
 
FUM.L Futura Medical plc
30.38
-1.06%
 
POLB.L Poolbeg Pharma PLC
5.15
-8.04%
 
SBTX.L SkinBioTherapeutics plc
16.00
+1.59%
 
SCLP.L Scancell Holdings plc
10.10
+3.59%
 
IMM.L ImmuPharma plc
3.5500
+1.43%
 
OXB.L Oxford Biomedica plc
410.00
-0.49%
 
ROQ.L Roquefort Therapeutics plc
3.6500
-9.88%
 
IBT-B.ST Infant Bacterial Therapeutics AB (publ)
49.30
-2.57%